Premarin cream and the risk for ovarian cancer

Ultima Vez Modificado: 31 de mayo del 2003

Share article


Question

Dear OncoLink "Ask The Experts,"
My wife is 58 and experienced menopause 5 years ago. Her GYN suggested that she use Premarin Cream to relieve a dry vagina problem and help when we have intercourse. I have heard of a link between Premarin and ovarian cancer. I am afraid for my wife to use the cream. Is my fear justified? Is there a "safe" cream that she can use? 

Answer

Christina S. Chu, MD, Assistant Professor of the Division of Gynecologic Oncology at the University of Pennsylvania Health System, responds:

The studies concerning estrogen replacement therapy and the risk for ovarian cancer are mixed. Some studies show no increase in risk, and others show an increase in risk for long-time users of estrogen alone (not estrogen given with progesterone). The most recent large study published in 2002 in the Journal of the American Medical Association showed approximately 60% increased risk. The authors did note that many women received doses of estrogen that were higher than are in use today, and while the type of estrogen replacement therapy was not defined, in general, usage refers to oral pills, or use of an estrogen patch. The risks of using vaginal Premarin cream are minimal, since it is not needed daily, and is only absorbed into the circulation in small amounts. In the right circumstances, estrogen cream can provide patients with much needed relief from their symptoms. Sometimes, estrogen is the only medication that can effectively treat atrophy (dry, itchy, painful, thin skin) of the vagina. If your wife is only having discomfort during intercourse and she would still like to avoid estrogen cream, instead of Premarin cream, she could try any of the over the counter water-based vaginal lubricants such as KY Jelly or Astroglide.


News
Society of Gynecologic Oncology document reviews etiology, risks, early detection

Oct 14, 2010 - he Society of Gynecologic Oncologists (SGO) has issued a comprehensive white paper -- as part the organization's professional GynecoLogic Cancer Collaborative education program -- that provides an overview of and background on the screening, diagnosis, and management of ovarian cancer. The report is published in the October issue of Gynecologic Oncology.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información